Chakma Justin (CIK 0001951238)

Latest company ownership

SPRY - ARS Pharmaceuticals, Inc.

Role: Chief Business Officer

Shares held

30,000

Last filed at

Nov 14, 2025

Confidence Score

25.5

2025Q4

Confidence Score History

2024Q4 2025Q4

Recent buy/sell transactions

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Nov 12, 2025	Nov 14, 2025	ARS Pharmaceuticals, Inc.	Chief Business Officer	Sell	17.5	-166,380	-100.00%	✗	$1.5M
Dec 12, 2024	Dec 13, 2024	ARS Pharmaceuticals, Inc.	Chief Business Officer	Sell	17.5	-144,605	-34.65%	✗	$1.8M
Dec 10, 2024	Dec 12, 2024	ARS Pharmaceuticals, Inc.	Chief Business Officer	Sell	20.0	-50,000	-26.83%	✗	$657.6K
Dec 4, 2024	Dec 6, 2024	ARS Pharmaceuticals, Inc.	Chief Business Officer	Sell	17.5	-144,640	-26.12%	✗	$2M
Dec 2, 2024	Dec 4, 2024	ARS Pharmaceuticals, Inc.	Chief Business Officer	Sell	17.5	-90,000	-24.81%	✗	$1.2M
Nov 25, 2024	Nov 27, 2024	ARS Pharmaceuticals, Inc.	Chief Business Officer	Sell	17.5	-100,000	-42.30%	✗	$1.4M